The advanced tool will also arrive on Galaxy Watch 8, Watch 7, and Ring ...

The obstructive sleep apnea competitive landscape report delivers important insights into approved as well as ongoing research on 22+ pipeline obstructive sleep apnea drugs, clinical strategies, ...

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as ...

Retatrutide is gaining attention for its weight-loss potential, but new clinical trials suggest it may also improve sleep apnea. Here’s what the findings mean for patients and treatment.

Samsung announced a new, advanced version of its AI-powered sleep apnea detection, and which devices it will appear on ...

Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

Samsung's advanced sleep apnea detection feature has received clearances from the US FDA and the Korean Ministry of Food and ...

An experimental medicine could eventually offer a drug-based approach to some breathing problems during sleep, according to ...

During Down Syndrome Awareness Month, Joe DiMaggio Children's Hospital is celebrating its first successful implantation of an ...

In two phase 3 trials, retatrutide significantly reduced sleep apnea severity and produced substantial weight loss in adults with overweight and obesity, with or without comorbid type 2 diabetes.

A scoping review of 11 studies finds associations between obstructive sleep apnea and long COVID that vary in direction and ...

An experimental weekly weight-loss injection substantially reduced breathing interruptions during sleep in two late-stage clinical trials. The results suggest a new possible approach to treating sleep ...